Author

G. K. Owens

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

L. S. Shankman· 3 shared S. Karnewar· 3 shared G. F. Alencar· 2 shared R. A. Deaton· 2 shared V. KARNEWAR· 2 shared A. Salamon· 1 shared B. Kull· 1 shared C. Williams· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

L. S. Shankman

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mouse Model of Heart Attack and Stroke Shows Improved Survival with MPO Inhibition

S. Shamsuzzaman, R. A. Deaton, H. Doviak, M. Evans, A. Salamon, S. Karnewar, V. Serbulea, G. F. Alencar, L. S. Shankman, K. Walsh, S. Bekiranov, O. Kocher, M. Kreiger, B. Kull, M. Persson, , G. K. Owens

The paper introduces a mouse model of advanced atherosclerosis that exhibits spontaneous plaque rupture leading to MI or stroke, and shows that MPO inhibition with AZM198 reduces mortality and plaque rupture incidence.

Circulation · Aug 27, 2024Peer-reviewedPhysiology

IL-1β inhibition partially negates the beneficial effects of diet-induced lipid lowering

S. Karnewar, V. KARNEWAR, R. A. Deaton, L. S. Shankman, E. Benavente, C. Williams, X. Bradley, G. F. Alencar, G. Bulut, S. Kirmani, R. Baylis, E. Zunder, H. H. den Ruijter, G. Pasterkamp, G. K. Owens

This study shows that inhibiting IL-1β in mice reduces the beneficial effects of diet-induced lipid lowering on atherosclerosis, increasing plaque burden and decreasing plaque stability.

bioRxiv · Oct 13, 2023 · PreprintCell Biology

Treatment of advanced atherosclerotic mice with the senolytic agent ABT-263 is associated with reduced indices of plaque stability and increased mortality

S. Karnewar, V. Karnewar, L. S. Shankman, G. K. Owens

Treatment of advanced atherosclerotic Apoe-/- mice with ABT-263 reduced SMC and increased EC contributions to lesions but decreased fibrous cap thickness and increased mortality.

bioRxiv · Jul 12, 2023 · PreprintCell Biology